| Identification | Back Directory | [Name]
Benzonitrile, 2-[[3,4-dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-[(1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)amino]-1-piperidinyl]-1(2H)-pyrimidinyl]methyl]-4-fluoro- | [CAS]
2204313-59-5 | [Synonyms]
Benzonitrile, 2-[[3,4-dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-[(1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)amino]-1-piperidinyl]-1(2H)-pyrimidinyl]methyl]-4-fluoro- | [Molecular Formula]
C23H24FN7O4 | [MOL File]
2204313-59-5.mol | [Molecular Weight]
481.48 |
| Hazard Information | Back Directory | [Uses]
(R)-4-Fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile is an impurity of Trelagliptin. Trelagliptin (Zafatek) is a pharmaceutical drug used for the treatment of type 2 diabetes. |
|
|